Investigators in India should use the DBT ”R&D proposal format” available at http://dbtindia.nic.in
and submit 1 soft copy of the of full length proposal duly forwarded by competent authority, by post to Dr. Vamsi Krishna, Scientist‑D, Department of Biotechnology, Room No. 726, Block‑2, CGO Complex, Lodhi Road, New Delhi – 110003. Email: firstname.lastname@example.org Corresponding online application should also be made at www.dbtepromis.nic.in, under the area “Medical Biotechnology-Vaccine Research and Diagnosis” which would be mandatory. The Indian side PI is requested to provide a 2 – 3 page document, from the US partner, in the proposal consisting of the objectives, methodology, the need for and the role of the Indian PI, and the timelines of the US side proposal along with the IPR issues as well as justification for Indo-US collaboration.
Investigators in USA should follow RO1 application guidelines and applications should be submitted to NEI/NIH directly, with reference to their Funding Opportunity Announcement (FOA) by referring to the weblink (link). DBT will support research activities within India, salaries of Indian research personnel, and other expenses. NIH funding will similarly support salaries of U.S. personnel and research activities within the U.S.A. All applications are competitive and will be considered on merit as per the standing policy of NEI/NIH and DBT.
Last Date for receiving Application: 9th November, 2017
For more information click here.